Product type
Dabigatran Etexilate is an oral anticoagulant medication used to prevent blood clots and reduce the risk of stroke in patients with certain types of heart conditions. It is a prodrug that is converted in the body to its active form, dabigatran, which inhibits thrombin, a key enzyme in the blood coagulation process. This mechanism helps to maintain proper blood flow and prevent thromboembolic events.
| Chemical Formula | C34H41N7O5S |
| Molecular Weight | 627.8 g/mol |
| Purity | Typically ≥ 98% |
| Form | Powder or crystalline form |
| Solubility | Soluble in water and organic solvents |
When selecting Dabigatran Etexilate as a pharmaceutical raw material, buyers should consider the required purity levels and the specific form needed for their applications. It is important to specify the desired quantity, as well as any necessary certifications such as GMP compliance. Buyers may also want to inquire about the supplier's capability to provide documentation for quality control and batch testing.
Get quotes for Dabigatran Etexilate
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
It is primarily used as an anticoagulant to prevent blood clots.
It is typically administered orally in capsule form.
Common side effects include bleeding, gastrointestinal issues, and allergic reactions.
No, it is not recommended for patients with certain conditions such as active bleeding or severe renal impairment.
Patients should be monitored for signs of bleeding and renal function.
It may interact with other medications, so consulting a healthcare provider is essential.